Added to YB: 2026-01-15
Pitch date: 2026-01-13
USAQ [neutral]
QHSLab, Inc.
-8.36%
current return
Author Info
Byron Street Research is an investment publication featuring a weekly event-driven idea generator, write-ups modeled in the familiar format of sell-side equity research reports, and performance reviews structured as traditional fund factsheets. Sign up for the newsletter.
Company Info
QHSLab, Inc., a medical device technology and software-as-a-service (SaaS) company, provides tools to evaluate and treat chronic disease and preventive care through reimbursable procedures.
Market Cap
$11.4M
Pitch Price
$0.82
Price Target
N/A
Dividend
N/A
EV/EBITDA
53.25
P/E
-20.95
EV/Sales
4.91
Sector
Health Care Technology
Category
growth
Catalyst Watch - QHSLab, Inc.
USAQ (update): Health tech co reported $1.99M revenue (+32% YoY) for 9M 2025. Q4 run rate continued rising. Eliminated $1.4M convertible debt (down to $20K), cutting annual interest expense $250K+. Mgmt expects cash flow positive operations exiting 2025, anticipates FY25 net income.
Read full article (1 min)